Search This Blog

Wednesday, 26 November 2014

Drugs to Fight Cardiovascular Damage: 2014 EACPT Focus Meeting: July 3-5, 2014 in Nijmegen, the Netherlands

The 2014 EACPT Focus Meeting was on the theme of 'Drugs to Fight Cardiovascular Damage'. This 2014 EACPT Focus Meeting took place from July 3rd - 5th at the Radboud University Medical Center in Nijmegen in the Netherlands.

The 2014 EACPT Focus Meeting

  • continued excellent tradition of EACPT in providing outstanding meetings for young and senior clinicians and researchers
  • provided delegates with the opportunity to attend state of the art lectures from leading professionals and researchers, including hands-on workshops. 
  • provided great opportunities for networking with your peers and senior members of the international clinical pharmacology community
  • gave easy access for delegates to senior researchers on the international speaker faculty 
  • gave the opportunity to have first hand news on major developments for EACPT
  • allowed delegates to meet Dr Richard Shader, the editor of the EACPT's Official Journal - Clinical Therapeutics 
  • provided delegates with an expert session from Dr Shader on how to publish
In addition to state-of-the-art lectures from international cardiovascular experts, over 60 delegate abstracts were presented  from around the world, with the top 5 ranked abstract presenters  provided with free registration. All abstracts presented at the meeting were published in Clinical Therapeutics, the peer-reviewed Official Journal of the EACPT. 

Selected publications based on the lectures at the Focus Meeting will be published in Clinical Therapeutics. 

This focus meeting follows on from the highly rated  EACPT international summer school in 2013 in Edinburgh.

Radboud University Medical Centre, Nijmegen 
Topics included ultrasound imaging of vascular injury (including a hands-on workshop), the microbiome and inflammation in the metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, and protection against ischaemia-reperfusion injury.

This EACPT Cardiovascular Focus Meeting was attended by clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. 

You can listen here to podcasts with international delegates at the last EACPT summer meeting in Edinburgh in 2013.

Visit the Clinical Therapeutics website.

No comments:

Post a Comment